MRI findings in an immunocompromised boy with CNS fungal infection.
Glass
Hannah C
HC
Department of Neurology, University of California, San Francisco, USA.
Wirrell
Elaine
E
Sarnat
Harvey B
HB
Dunham
Christopher
C
Lewis
Victor
V
Morrish
William
W
D000935:Antifungal Agents / Q000627:therapeutic use; D001921:Brain / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology; D001922:Brain Abscess / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D001929:Brain Edema / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D020314:Central Nervous System Fungal Infections / Q000276:immunology* / Q000473:pathology* / Q000503:physiopathology; D002648:Child; D003244:Consciousness Disorders / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D018450:Disease Progression; D017809:Fatal Outcome; D006261:Headache / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D016867:Immunocompromised Host / Q000276:immunology*; D015458:Leukemia, T-Cell / Q000150:complications* / Q000276:immunology* / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008297:Male; D020953:Neuroaspergillosis / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D010291:Paresis / Q000382:microbiology / Q000473:pathology / Q000503:physiopathology; D017211:Treatment Failure
D000935:Antifungal Agents